Paul Roach
Royal North Shore Hospital, NSW, Australia
Presentations this author is a contributor to:
A retrospective study of dual 18F-fluorodeoxyglucose/68Gallium DOTATATE (FDG/68Ga-DOTATATE) positron emission tomography (PET) grading and its prognostic value in metastatic pancreatic neuroendocrine tumours (PNET) (#349)
3:00 PM
David L Chan
Posters 2
Experience of Australia and New Zealand (ANZ) patients with neuroendocrine tumours (NET) treated at a NET specialist centre: Results of a national survey and the Royal North Shore experience (#350)
3:00 PM
David L Chan
Posters 2